Targeting SF3B1 as a novel therapeutic strategy against diffuse malignant peritoneal mesothelioma
Suprasplicesome meeting, Amsterdam, 23 September 2019
Presentation by Elisa Giovannetti: “Targeting SF3B1 as a novel therapeutic strategy against diffuse malignant peritoneal mesothelioma”
Presentation PDF: Targeting SF3B1 as a novel therapeutic strategy against diffuse malignant peritoneal mesothelioma
The results of this study have been published in EBiomedicine:
www.ebiomedicine.com/article/S2352-3964(18)30602-9
Article PDF: Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma
with a dedicated editorial: www.ncbi.nlm.nih.gov/pubmed/30612942
